Louisville Medicine Volume 64, Issue 3 | Page 8

PAIN: THE FIFTH VITAL SIGN Waqar Aziz, MD "Every form of addiction is bad, no matter whether the narcotic be alcohol, morphine or idealism." - C.G. Jung P ain management is the topic on every provider’s mind these days. Since the Centers for Disease Control’s latest statistics reported 28,000 opioid deaths in 2014, with over half of those deaths from prescribed opioids, the pain management climate has changed. The monster that is being created in the United States is very real. We have all seen patients come into the recovery room rating their pain a 10 without being asked and still so drowsy from anesthesia they are slurring their words. In the provider offices, teenagers will come in smiling but say their sprained ankle pain is a 10/10, when just a few years ago these same teens would have continued their sports, never reporting their pain for fear of being put on the sidelines. The United States prescribes 80 percent of the world’s opioid prescriptions. It is hard to believe that our country has more pain than all other countries combined. When pain started being assessed as the fifth vital sign, a Pandora’s Box was opened that has let forth a multitude of woes and everyone in health care is in crisis mode. According to an April 18, 2016, Joint Commission statement on pain management issued by Dr. David Baker, Executive VP of Healthcare Quality Evaluation with Joint Commission, there are five misconceptions about JCAHO standards that he feels need to be addressed: • The Joint Commission endorses pain as a vital sign. • The Joint Commission requires pain assessment for all patients. • The Joint Commission requires pain be treated until the pain score reaches zero. • The Joint Commission pain standards push doctors to pre6 LOUISVILLE MEDICINE scribe opioids. • The Joint Commission pain standards caused a sharp rise in opioid prescriptions. In the quest to find someone to blame for the current epidemic, he feels JCAHO has been unduly singled out. Dr. Baker states it was never JCAHO’s intent for pain to be assessed as a vital sign or the use of opioids to get patients' pain to a zero. In 1995, then President of the American Pain Society, Dr. James Campbell contended that by addressing pain just like other vital signs we would assure that pain was considered at each and every patient encounter. This idea caught the attention of not only JCAHO but also the Veterans Health Administration (VHA). Having these two powerful organizations on board helped the adoption of the current standards used throughout the United States for pain assessment. Pharmaceutical companies delivered long-acting opioids such as OxyContin, the opioid that would treat pain but not addict the patient. It was considered unlikely to be abused because of the time-released coating. There has been a 300 percent increase in subscribed opioids over the past years and patients quickly learned how to crush, snort and inject these medications, not always with the best of results. Emergency room visits for abscesses, cellulitis, DVTs, overdoses and death from injecting medications that were never meant to be used intravenously soared. In 2010, over 12 million Americans said they used opiates for causes other than their intended use. Patients quickly found the magic number that would get them the pain medication they wanted. They also knew what diagnoses would get the prescriptions they wanted and be difficult for providers to refute. Soon there was an increase in diagnoses of back pain,